Cargando…

Evaluation of a SARS-CoV-2 lateral flow assay using the plaque reduction neutralization test

As new tests and technologies advance our understanding and diagnostic capabilities of the severe acute respiratory syndrome coronavirus 2 and the coronavirus disease 2019, they must be appropriately validated to make sure test performance is following manufacturer claims. In this study, we evaluate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xie, Xuping, Nielsen, Marisa C., Muruato, Antonio E., Fontes-Garfias, Camila R., Ren, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7562965/ https://www.ncbi.nlm.nih.gov/pubmed/33130510 http://dx.doi.org/10.1016/j.diagmicrobio.2020.115248

Ejemplares similares

A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation
por: Muruato, Antonio E., et al.
Publicado: (2020)

A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation
por: Muruato, Antonio E., et al.
Publicado: (2020)

Author Correction: A high-throughput neutralizing antibody assay for COVID-19 diagnosis and vaccine evaluation
por: Muruato, Antonio E., et al.
Publicado: (2021)

A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19
por: Xie, Xuping, et al.
Publicado: (2020)

Author Correction: A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti-infective drugs for COVID-19
por: Xie, Xuping, et al.
Publicado: (2021)

Spike mutation D614G alters SARS-CoV-2 fitness and neutralization susceptibility
por: Shi, Pei-Yong, et al.
Publicado: (2020)

Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera
por: Shi, Pei-Yong, et al.
Publicado: (2021)

The effect of SARS-CoV-2 D614G mutation on BNT162b2 vaccine-elicited neutralization
por: Zou, Jing, et al.
Publicado: (2021)

Validation and Establishment of the SARS-CoV-2 Lentivirus Surrogate Neutralization Assay as a Prescreening Tool for the Plaque Reduction Neutralization Test
por: Merluza, John, et al.
Publicado: (2023)

Spike mutation D614G alters SARS-CoV-2 fitness and neutralization susceptibility
por: Plante, Jessica A., et al.
Publicado: (2020)

Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera
por: Xie, Xuping, et al.
Publicado: (2021)

Comparison of JEV neutralization assay using pseudotyped JEV with the conventional plaque-reduction neutralization test
por: Lee, Hee-Jung, et al.
Publicado: (2014)

Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization Assays
por: Valcourt, Emelissa J., et al.
Publicado: (2021)

BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants
por: Liu, Yang, et al.
Publicado: (2021)

Evaluating ELISA, Immunofluorescence, and Lateral Flow Assay for SARS-CoV-2 Serologic Assays
por: Michel, Moïse, et al.
Publicado: (2020)

Rapid lateral flow tests for the detection of SARS-CoV-2 neutralizing antibodies
por: Wang, Jianfu J., et al.
Publicado: (2021)

Evaluation of a rapid semiquantitative lateral flow assay for the prediction of serum neutralizing activity against SARS-CoV-2 variants
por: Hirabidian, Mickael, et al.
Publicado: (2022)

Neutralization Titers in Vaccinated Patients with SARS-CoV-2 Delta Breakthrough Infections
por: Zou, Jing, et al.
Publicado: (2022)

Evaluation of a commercial ELISA as alternative to plaque reduction neutralization test to detect neutralizing antibodies against SARS-CoV-2
por: Hofmann, Natalie, et al.
Publicado: (2022)

Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K, and N501Y variants by BNT162b2 vaccine-elicited sera
por: Xie, Xuping, et al.
Publicado: (2021)

Enhancing sensitivity of lateral flow assay with application to SARS-CoV-2
por: Peng, Tao, et al.
Publicado: (2020)

SARS-CoV-2 enzyme-linked immunosorbent assays as proxies for plaque reduction neutralisation tests
por: Kay, Grant A., et al.
Publicado: (2022)

An Integrated Research–Clinical BSL-2 Platform for a Live SARS-CoV-2 Neutralization Assay
por: Zou, Jing, et al.
Publicado: (2023)

Evaluation of Simple Lateral Flow Immunoassays for Detection of SARS-CoV-2 Neutralizing Antibodies
por: Nickel, Olaf, et al.
Publicado: (2022)

Correction for Valcourt et al., “Evaluating Humoral Immunity against SARS-CoV-2: Validation of a Plaque-Reduction Neutralization Test and a Multilaboratory Comparison of Conventional and Surrogate Neutralization Assays”
por: Valcourt, Emelissa J., et al.
Publicado: (2022)

Neutralization of SARS-CoV-2 Omicron sublineages by 4 doses of mRNA vaccine
por: Xie, Xuping, et al.
Publicado: (2022)

A Molecular Lateral Flow Assay for SARS-CoV-2 Quantitative Detection
por: Maglaras, Panagiotis, et al.
Publicado: (2022)

Neutralization of SARS-CoV-2 Omicron sublineages by 4 doses of the original mRNA vaccine
por: Xie, Xuping, et al.
Publicado: (2022)

Performance assessment of SARS-CoV-2 IgM & IgG ELISAs in comparison with plaque reduction neutralization test
por: Kulkarni, Ruta, et al.
Publicado: (2021)

Distinct neutralizing kinetics and magnitudes elicited by different SARS-CoV-2 variant spikes
por: Liu, Yang, et al.
Publicado: (2021)

Correction for Zhou et al., “Neutralization Titers in Vaccinated Patients with SARS-CoV-2 Delta Breakthrough Infections”
por: Zou, Jing, et al.
Publicado: (2022)

Performance of lateral flow assays for SARS-CoV-2 compared to RT-qPCR
por: Pilecky, Matthias, et al.
Publicado: (2022)

Sandwich mode lateral flow assay for point-of-care detecting SARS-CoV-2
por: Pei, Fubin, et al.
Publicado: (2023)

Development of nucleic acid based lateral flow assays for SARS-CoV-2 detection
por: Çam Derin, Dilek, et al.
Publicado: (2023)

Lateral flow assays
por: Koczula, Katarzyna M., et al.
Publicado: (2016)

Letter to the editor RE: Fulford et al., 2021 ‘A point-of-care lateral flow assay for neutralizing antibodies against SARS-CoV-2’
por: Lake, Douglas F., et al.
Publicado: (2022)

Author Correction: Spike mutation D614G alters SARS-CoV-2 fitness
por: Plante, Jessica A., et al.
Publicado: (2021)

A Lateral Flow Immunoassay Coupled with a Spectrum-Based Reader for SARS-CoV-2 Neutralizing Antibody Detection
por: Huang, Rui-Lin, et al.
Publicado: (2022)

Cross-neutralization of Omicron BA.1 against BA.2 and BA.3 SARS-CoV-2
por: Zou, Jing, et al.
Publicado: (2022)

Neutralization against Omicron SARS-CoV-2 from previous non-Omicron infection
por: Zou, Jing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_261pe22iki1g12tddnp2r7h0s2